233 related articles for article (PubMed ID: 15514900)
1. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia.
Viola A; Chabrol B; Nicoli F; Confort-Gouny S; Viout P; Cozzone PJ
Pediatr Res; 2002 Aug; 52(2):292-300. PubMed ID: 12149509
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia.
Bjoraker KJ; Swanson MA; Coughlin CR; Christodoulou J; Tan ES; Fergeson M; Dyack S; Ahmad A; Friederich MW; Spector EB; Creadon-Swindell G; Hodge MA; Gaughan S; Burns C; Van Hove JL
J Pediatr; 2016 Mar; 170():234-9. PubMed ID: 26749113
[TBL] [Abstract][Full Text] [Related]
4. Practical difficulties in the diagnosis of transient non-ketotic hyperglycinaemia.
Lang TF; Parr JR; Matthews EE; Gray RG; Bonham JR; Kay JD
Dev Med Child Neurol; 2008 Feb; 50(2):157-9. PubMed ID: 18201306
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia.
Tsuyusaki Y; Shimbo H; Wada T; Iai M; Tsuji M; Yamashita S; Aida N; Kure S; Osaka H
Brain Dev; 2012 Jan; 34(1):72-5. PubMed ID: 21316884
[TBL] [Abstract][Full Text] [Related]
6. Early myoclonic encephalopathy and nonketotic hyperglycinemia.
Rossi S; Daniele I; Bastrenta P; Mastrangelo M; Lista G
Pediatr Neurol; 2009 Nov; 41(5):371-4. PubMed ID: 19818941
[TBL] [Abstract][Full Text] [Related]
7. Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation.
Korman SH; Wexler ID; Gutman A; Rolland MO; Kanno J; Kure S
Ann Neurol; 2006 Feb; 59(2):411-5. PubMed ID: 16404748
[TBL] [Abstract][Full Text] [Related]
8. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
[TBL] [Abstract][Full Text] [Related]
9. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
Chien YH; Hsu CC; Huang A; Chou SP; Lu FL; Lee WT; Hwu WL
J Child Neurol; 2004 Jan; 19(1):39-42. PubMed ID: 15032382
[TBL] [Abstract][Full Text] [Related]
10. Late-onset nonketotic hyperglycinemia caused by a novel homozygous missense mutation in the GLDC gene.
Brunel-Guitton C; Casey B; Coulter-Mackie M; Vallance H; Hewes D; Stockler-Ipsiroglu S; Mercimek-Mahmutoglu S
Mol Genet Metab; 2011 Jun; 103(2):193-6. PubMed ID: 21411353
[TBL] [Abstract][Full Text] [Related]
11. Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia.
Cusmai R; Martinelli D; Moavero R; Dionisi Vici C; Vigevano F; Castana C; Elia M; Bernabei S; Bevivino E
Eur J Paediatr Neurol; 2012 Sep; 16(5):509-13. PubMed ID: 22261077
[TBL] [Abstract][Full Text] [Related]
12. Nonketotic hyperglycinemia in a newborn infant.
Tekinalp G; Coşkun T; Oran O; Ozalp I; Figen G; Ergin H
Turk J Pediatr; 1995; 37(1):57-60. PubMed ID: 7732609
[TBL] [Abstract][Full Text] [Related]
13. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
[TBL] [Abstract][Full Text] [Related]
14. Nonketotic hyperglycinemia: report of a case and review of the clinical, chemical, and pathological changes.
Slager UT; Berggren RL; Marubayashi S
Ann Neurol; 1977 Apr; 1(4):399-402. PubMed ID: 617256
[TBL] [Abstract][Full Text] [Related]
15. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
Zammarchi E; Donati MA; Ciani F; Pasquini E; Pela I; Fiorini P
Neuropediatrics; 1994 Oct; 25(5):274-6. PubMed ID: 7885541
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia.
Alemzadeh R; Gammeltoft K; Matteson K
Pediatrics; 1996 Jun; 97(6 Pt 1):924-6. PubMed ID: 8657542
[TBL] [Abstract][Full Text] [Related]
17. Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation.
Korman SH; Boneh A; Ichinohe A; Kojima K; Sato K; Ergaz Z; Gomori JM; Gutman A; Kure S
Ann Neurol; 2004 Jul; 56(1):139-43. PubMed ID: 15236413
[TBL] [Abstract][Full Text] [Related]
18. Intracerebral blood and MRS in neonatal nonketotic hyperglycinemia.
Manley BJ; Sokol J; Cheong JL
Pediatr Neurol; 2010 Mar; 42(3):219-22. PubMed ID: 20159434
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
